Optimi Health Corp. (FRA:8BN)
Germany · Delayed Price · Currency is EUR 0.2080
+0.0020 (0.97%)
At close: Nov 28, 2025
Optimi Health Company Description
Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.
The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.
The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products.
It sells its products through Amazon marketplace and distributors/brokers, as well as online. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020.
Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Optimi Health Corp.
| Country | Canada |
| Founded | 2020 |
| Industry | Medicinal Chemicals and Botanical Products |
| CEO | Dane Stevens |
Contact Details
Address: 269 David Brown Way Princeton, British Columbia V0X 1W0 Canada | |
| Phone | 778-761-4551 |
| Website | optimihealth.ca |
Stock Details
| Ticker Symbol | 8BN |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Dane Stevens | Chief Executive Officer |
| Jacob Safarik | Chief Financial Officer |
| Bryan Safarik | Chief Operating Officer |